EXAS - Exact Sciences Corp - SEC Form 4 Insider Trading Screener

Services - Engineering, Accounting, Research, Management Services - Commercial Physical & Biological Research - EXAS (1124140)
General
Tickers
Insider
Sh Price $
Lqdty M$
Date
Filing Date
  
Trade Date
  
Filing Delay
N Days Ago
Transaction Filing
P - Purchase
S - Sale
A - Grant
D - Sale to Iss
G - Gift
F - Tax
M - Option Ex
X - Option Ex
C - Cnv Deriv
W - Inherited
No deriv Multiple Days
Traded K$
Own Chg %
Industry
Insider Title   Officer
    COB
    CEO
    Pres
    COO
    CFO
    GC
    VP
  Director
  10% Own
  Other
Group by
Sort by
Max Results
Page
clear
Real-time CSV, Options, Alerts
55 results - Yahoo - Google - Finviz - Stockcharts - Tradingview - Stocktwits - SEC
TCcnt1d1w1m6m
P3+2+4+12+8
S16-2+2+5+11

X

Filing Date

Trade Date

Ticker

Insider Name

Insider Title

Trade Type 

Share Price

Shares Traded

Shares Owned

Own chg

Value Traded

1d ret

1w ret

1m ret

6m ret

D
2018-07-02
EXASCoward D ScottSVP, GCS - Sale+OE$59.10-2,13577,048-3%-$126,176
2018-05-10
EXASWyzga Michael SDirS - Sale$51.53-7,40210,974-40%-$381,447
2018-04-12
EXASZanotti Katherine SDirS - Sale$45.00-7,232105,814-6%-$325,440
2018-04-10
EXASDoyle James EdwardDirS - Sale$40.97-3,09835,181-8%-$126,925
2018-04-10
EXASCarey Thomas D.DirS - Sale$39.73-8,44852,410-14%-$335,630
D
2018-04-02
EXASCoward D ScottSVP, GCS - Sale+OE$40.12-2,12270,690-3%-$85,124
DM
2018-03-09
EXASLidgard Graham PeterChief Science OfficerS - Sale+OE$51.98-14,550206,289-7%-$756,271
D
2018-03-12
EXASCoward D ScottSVP, GCS - Sale+OE$52.19-2,70868,124-4%-$141,341
D
2018-03-12
EXASConroy Kevin TPres, CEOS - Sale+OE$52.19-11,459973,208-1%-$598,091
D
2018-03-12
EXASArora ManeeshCOOS - Sale+OE$52.19-5,295658,613-1%-$276,367
ADM
2018-02-26
EXASLidgard Graham PeterChief Science OfficerS - Sale+OE$43.10-39,884206,289-16%-$1,718,847
D
2018-02-27
EXASArora ManeeshCOOS - Sale+OE$44.10-5,512652,633-1%-$243,068
DM
2018-02-26
EXASLidgard Graham PeterChief Science OfficerS - Sale+OE$42.88-35,025211,148-14%-$1,501,960
D
2018-02-27
EXASConroy Kevin TPres, CEOS - Sale+OE$44.10-9,085960,267-1%-$400,630
DM
2018-02-23
EXASLidgard Graham PeterChief Science OfficerS - Sale+OE$40.44-27,428218,936-11%-$1,109,266
D
2018-02-26
EXASElliott Jeffrey ThomasCFOS - Sale+OE$42.34-2,98221,793-12%-$126,252
D
2018-02-26
EXASCoward D ScottSVP, GCS - Sale+OE$42.34-4,42052,699-8%-$187,134
D
2018-02-26
EXASConroy Kevin TPres, CEOS - Sale+OE$42.34-25,319949,327-3%-$1,071,956
D
2018-02-26
EXASArora ManeeshCOOS - Sale+OE$42.34-12,352645,995-2%-$522,959
D
2018-02-09
EXASConroy Kevin TPres, CEOS - Sale+OE$45.72-101,488920,241-10%-$4,640,272
D
2018-01-23
EXASConroy Kevin TPres, CEOS - Sale+OE$50.49-110,439920,241-11%-$5,575,961
D
2018-01-12
EXASConroy Kevin TPres, CEOS - Sale+OE$52.80-125,402920,231-12%-$6,620,593
D
2018-01-03
EXASCoward D ScottSVP, GCS - Sale+OE$52.54-1,66543,943-4%-$87,474
D
2017-12-22
EXASConroy Kevin TPres, CEOS - Sale+OE$52.58-123,512920,231-12%-$6,494,790
D
2017-12-06
EXASConroy Kevin TPres, CEOS - Sale+OE$53.45-121,849920,231-12%-$6,513,179
2017-12-01
EXASLidgard Graham PeterChief Science OfficerS - Sale$58.27-45,770205,963-18%-$2,667,204
D
2017-11-21
EXASConroy Kevin TPres, CEOS - Sale+OE$59.50-134,057920,231-13%-$7,976,660
D
2017-11-09
EXASConroy Kevin TPres, CEOS - Sale+OE$59.14-137,805920,231-13%-$8,149,669
2017-11-01
EXASLidgard Graham PeterChief Science OfficerS - Sale$53.60-45,775251,733-15%-$2,453,768
D
2017-10-02
EXASLidgard Graham PeterChief Science OfficerS - Sale+OE$47.16-81,025297,508-21%-$3,820,734
D
2017-10-02
EXASCoward D ScottSVP, GCS - Sale+OE$47.16-29,11539,239-43%-$1,373,115
D
2017-09-05
EXASLidgard Graham PeterChief Science OfficerS - Sale+OE$40.81-75,683343,283-18%-$3,088,801
2017-09-01
EXASLidgard Graham PeterChief Science OfficerS - Sale$41.49-45,775300,966-13%-$1,899,205
2017-08-17
EXASCarey Thomas D.DirP - Purchase$37.71+2,50060,858+4%+$94,275
D
2017-07-31
EXASElliott Jeffrey ThomasCFOS - Sale+OE$39.41-5,84614,487-29%-$230,391
D
2017-07-03
EXASCoward D ScottSVP, GCS - Sale+OE$35.21-1,98763,666-3%-$69,962
D
2017-04-03
EXASCoward D ScottSVP, GCS - Sale+OE$23.74-1,54357,298-3%-$36,631-1+1+38
2017-03-13
EXASLidgard Graham PeterChief Science OfficerS - Sale$21.16-2,945343,170-1%-$62,3160+1+9
2017-03-13
EXASCoward D ScottSVP, GCS - Sale$21.16-1,98354,153-4%-$41,9600+1+9
2017-03-13
EXASConroy Kevin TPres, CEOS - Sale$21.16-12,059907,418-1%-$255,1680+1+9
2017-03-13
EXASArora ManeeshCOOS - Sale$21.16-5,574634,537-1%-$117,9460+1+9
DM
2017-02-24
EXASLidgard Graham PeterChief Science OfficerS - Sale+OE$21.51-8,668337,690-3%-$186,429+3+2+6
D
2017-02-27
EXASCoward D ScottSVP, GCS - Sale+OE$21.48-7,04650,111-12%-$151,348+3+2+6
DM
2017-02-24
EXASConroy Kevin TPres, CEOS - Sale+OE$21.51-27,134895,077-3%-$583,520+3+2+6
DM
2017-02-24
EXASArora ManeeshCOOS - Sale+OE$21.50-11,114628,836-2%-$238,968+3+2+6
D
2017-01-03
EXASCoward D ScottSVP, GCS - Sale+OE$13.61-1,53534,918-4%-$20,891+2+25+28
2016-12-14
EXASThompson DavidDirP - Purchase$13.84+10,000136,379+8%+$138,400+4+2+39
DM
2016-11-11
EXASLidgard Graham PeterChief Science OfficerS - Sale+OE$17.46-311,112257,256-55%-$5,431,793-16-13-21
DM
2016-11-11
EXASConroy Kevin TPres, CEOS - Sale+OE$17.46-600,000861,834-41%-$10,476,000-16-13-21
DM
2016-11-11
EXASArora ManeeshCOOS - Sale+OE$17.46-562,932608,736-48%-$9,829,534-16-13-21
D
2016-10-03
EXASCoward D ScottSVP, GCS - Sale+OE$17.98-1,70130,208-5%-$30,5840+5-16+21
2016-09-01
EXASSterling LionelDirP - Purchase$18.10+5,000121,247+4%+$90,500+2+2+1+16
2016-08-03
EXASZanotti Katherine SDirP - Purchase$17.93+3,380105,927+3%+$60,613+1+8-30
D
2016-07-26
EXASLidgard Graham PeterChief Science OfficerS - Sale+OE$14.82-7,383256,384-3%-$109,416+4+10+17+6
D
2016-07-26
EXASArora ManeeshCOOS - Sale+OE$14.82-7,359608,736-1%-$109,060+4+10+17+6

Real-time CSV? Options? Alerts? Contact us!
AAmended filing
DDerivative transaction in filing (usually option exercise)
EError detected in filing
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top